BARIcitinib Cognitive Emotional and Neural signaTuRE

PHASE4

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped Difficulties of inclusion in the study following expiry of the experimental treatment. The time required to supply the study treatment is too long to obtain conclusive results at the end of the study.

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Baricitinib Oral Tablet [Olumiant]
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris